A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
CCG Community of Practice Bookmark and Share

Clinical Cancer Genetics Community of Practice

City of Hope Clinical Cancer Genetics Community of Practice brings cancer genetics practitioners from diverse practice settings together for professional learning, enduring patient-centered support and dynamic community-based research collaborations to promote quality care and improved patient outcomes across the U.S. and internationally.
 
Working Group
 
Clinical Cancer Genetics (CCG) Working Group is a CME-accredited interdisciplinary cancer genetics case conference series conducted each week by the City of Hope clinical team.
 
TICGR Topics in Cancer Genetics Research
 
Topics in Clinical Cancer Genetics (TICGR) is a weekly one-hour CME-accredited web-conference seminar series focused on timely issues in clinical cancer genetics, cancer epidemiology and cancer genetics research, alternating between didactic lectures, case-based literature reviews and basic research journal club.
 

A Web-based discussion board for collaborative, interdisciplinary practice-based support and continuing professional learning.
 
Knowledge Center
 
Knowledge Center Information coming soon
 

A large research group of over 40 collaborating sites in the 40 collaborating sites in the United States, Mexico, and South America. As members of the CCGCRN, research collaborators can use the message board and forums to post questions and communicate with other members in the network.
 

CCG Community of Practice

Clinical Cancer Genetics Community of Practice

City of Hope Clinical Cancer Genetics Community of Practice brings cancer genetics practitioners from diverse practice settings together for professional learning, enduring patient-centered support and dynamic community-based research collaborations to promote quality care and improved patient outcomes across the U.S. and internationally.
 
Working Group
 
Clinical Cancer Genetics (CCG) Working Group is a CME-accredited interdisciplinary cancer genetics case conference series conducted each week by the City of Hope clinical team.
 
TICGR Topics in Cancer Genetics Research
 
Topics in Clinical Cancer Genetics (TICGR) is a weekly one-hour CME-accredited web-conference seminar series focused on timely issues in clinical cancer genetics, cancer epidemiology and cancer genetics research, alternating between didactic lectures, case-based literature reviews and basic research journal club.
 

A Web-based discussion board for collaborative, interdisciplinary practice-based support and continuing professional learning.
 
Knowledge Center
 
Knowledge Center Information coming soon
 

A large research group of over 40 collaborating sites in the 40 collaborating sites in the United States, Mexico, and South America. As members of the CCGCRN, research collaborators can use the message board and forums to post questions and communicate with other members in the network.
 
Clinical Cancer Genetics
The City of Hope Division of Clinical Cancer Genetics is committed to being a national leader in the advancement of cancer genetics, screening and prevention, through innovative patient care, research and education.

Contact Us
  • 800-826-HOPE (4673)
  • For more information about the Cancer Screening & Prevention Program, call 626-256-8662, ext. 2.
Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
City of Hope Breakthroughs
Get the latest in City of Hope's research, treatment and news you can use on our blog, Breakthroughs.
 
 


NEWS & UPDATES
  • To say that myelofibrosis patients need more treatment options would be an understatement. The severely low platelet counts, known as thrombocytopenia, that are one of the hallmark symptoms of the disease can lead to chronic fatigue and weakness that not only damage quality of life but, ultimately, shorten life...
  • Patients with metastatic colorectal cancer often stop responding to the primary drugs used against the disease, leaving them with few options and little hope. Determined to increase those options, doctors and researchers at City of Hope are conducting two clinical trials that could lead to new treatments for pe...
  • Investigators working at City of Hope are making many significant inroads against many forms of cancer. To do that, they have to take a variety of approaches. Molecular oncology researchers focus on abnormal cancer-associated activity in a cell’s nucleus. One especially prominent factor in many breast and ovari...
  • In light of the new breast cancer screening guidelines, which call for women to have mammograms every other year from age 50 to 74, it’s more important than ever for women to understand their individual risk. On Monday, the U.S. Preventive Services Task force released new breast cancer screening guideline...
  • Cancer patients need, and deserve, more than medical care. They and their families need high-quality supportive care – that is, care that addresses their physical, emotional and spiritual well-being. Health care professionals increasingly understand this, but starting such programs from scratch isn’t easy...
  • Each year, City of Hope patients given another chance at life gather to pose for a picture like this one. Going on its 39th year, the celebration of patients free of blood cancers thanks to bone marrow or stem cell transplants has grown such that a photographer has to scale a cherry picker just to […]
  • Cancer patients who are participating in early-stage clinical trials need extra emotional and physical support due to their additional stress and often unique symptoms. Now an effort by researchers at City of Hope to create a model for such support has received a $6.8 million grant from the National Cancer Inst...
  • The need for improvements in treating malignant brain tumors has never been greater. Survival for many patients with these tumors are sometimes measured in just months. One reason that therapeutic options are limited is that traditional surgery is deemed too risky for many brain tumors, especially for those in ...
  • “Honestly, there’s nothing special about my story,” protested Daniel Samson, as he bounced Layla, his 3 1/2-year-old daughter, on his lap and put on a video for her to watch. “I just want to tell it for my own sake, and share it with other men who may be going through this chaos.” Samson spoke […]
  • As far back as he can remember, Jonathan Yamzon, M.D., wanted to be a doctor. “I knew it from the get-go,” he said, matter-of-factly. “I always envisioned it as the ideal; the supreme thing one could do with one’s life.” The youngest of six children, Yamzon was barely a toddler when his family moved to [&...
  • There’s never a “good” time for cancer to strike. With testicular cancer, the timing can seem particularly unfair. This disease targets young adults in the prime of life; otherwise healthy people unaccustomed to any serious illness, let alone cancer. And suddenly … “I can only imagine what they must...
  • Sure, a healthy lifestyle can lower a person’s risk, but the impact of specific actions is harder to tease out. Diet, exercise, tobacco use, nutritional supplements, alcohol consumption … How important are each of these factors, individually? Does strict adherence to (or rejection of) one get you a pass o...
  • Health care decisions are tough. They’re even tougher when you – or loved ones – have to make them without a plan or a conversation. National Healthcare Decisions Day, on April 16,  is a nationwide initiative to demystify the health care decision-making process and encourage families to start talking. Ult...
  • The statistics, direct from the American Cancer Society, are sobering: Cancer death rates among African-American men are 27 percent higher than for white men. The death rate for African-American women is 11 percent higher compared to white women. Hispanics have higher rates of cervical, liver and stomach cancer...
  • “Lucky” is not usually a term used to describe someone diagnosed with cancer.  But that’s how 34-year-old Alex Camargo’s doctor described him when he was diagnosed with thyroid cancer — the disease is one of the most treatable cancers at all stages. That doctor was ultimately proved righ...